drugset / Trial / NCT03424707

A Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain

NCT03424707

Phase 2 Completed 45 enrolled Daewon Pharmaceutical Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

A Single-Center, Randomized, Double-Blind, Parallel, Pilot Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Pelubiprofen/Eperisone in Patients with Acute Low Back Pain

Timeline

Start
2016-03-04
Primary completion
2016-08-30
Completion
2016-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Eperisone Small molecule
Comparator Pelubiprofen Small molecule

Indications

No indication recorded.